CoreCap Advisors’s Ventyx Biosciences VTYX Stock Holding History

CoreCap Advisors’s Portfolio VTYX Stock Details VTYX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-561	Closed	-$1.23K	–	3318
2024 Q4	$1.23K	Buy	+561	New	+$1.27K	﹤0.01%	2340

Other funds holding VTYX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return

SCM

Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return

VPC

Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

CoreCap Advisors's VTYX Position: Q1 2025 in Review

CoreCap Advisors sold out of Ventyx Biosciences (VTYX) in Q1 2025, closing a stake of 561 shares — an estimated $1.23K sold.

CoreCap Advisors first reported a position in VTYX in Q4 2024 and held it in 1 quarter. The position peaked at $1.23K in Q4 2024. 116 funds tracked by Wall St. Rank hold VTYX as of Q1 2025.

CoreCap Advisors reported no remaining Ventyx Biosciences position as of Q1 2025 after selling out during the quarter.
CoreCap Advisors sold 561 Ventyx Biosciences shares in Q1 2025, an estimated $1.23K.
CoreCap Advisors first reported a position in Ventyx Biosciences in Q4 2024 and held it in 1 quarter.
CoreCap Advisors's Ventyx Biosciences position peaked at $1.23K in Q4 2024.
116 funds tracked by Wall St. Rank held Ventyx Biosciences as of Q1 2025.

Based on CoreCap Advisors's 13F filing for Q1 2025, filed 9 May 2025.